These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5663564)

  • 1. In vitro production of choleragen and vascular permeability factor by Vibrio cholerae.
    Evans DJ; Richardson SH
    J Bacteriol; 1968 Jul; 96(1):126-30. PubMed ID: 5663564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing in vitro skin permeability factor production by Vibrio cholerae.
    Richardson SH
    J Bacteriol; 1969 Oct; 100(1):27-34. PubMed ID: 5344097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.
    Finkelstein RA; LoSpalluto JJ
    J Exp Med; 1969 Jul; 130(1):185-202. PubMed ID: 4978880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of Biologically Active Substances by Two Strains of Vibrio cholerae.
    Kusama H; Craig JP
    Infect Immun; 1970 Jan; 1(1):80-7. PubMed ID: 16557700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cholera-like enterotoxin by a Vibrio cholerae non-O1 strain isolated from the environment.
    Craig JP; Yamamoto K; Takeda Y; Miwatani T
    Infect Immun; 1981 Oct; 34(1):90-7. PubMed ID: 7298194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activities of enterotoxin from Vibrio cholerae non-01.
    Hostacká A; Ciznár I; Korych B; Karolcek J
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):189-95. PubMed ID: 6193168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay.
    Evans DG; Evans DJ; Gorbach SL
    Infect Immun; 1973 Nov; 8(5):731-5. PubMed ID: 4584049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa].
    Dzhaparidze MN; Naumov AV; Nikitina GP; Meleshchenko MV; Dobrova GV; Zavorotnykh VI; Gracheva VP; Zakharova TL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):31-3. PubMed ID: 1882603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae.
    Sack RB; Carpenter CC
    J Infect Dis; 1969 Feb; 119(2):150-7. PubMed ID: 5776005
    [No Abstract]   [Full Text] [Related]  

  • 11. Medium-dependent production of extracellular enterotoxins by non-O-1 Vibrio cholerae, Vibrio mimicus, and Vibrio fluvialis.
    Nishibuchi M; Seidler RJ
    Appl Environ Microbiol; 1983 Jan; 45(1):228-31. PubMed ID: 6824317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic O antigen relationship of Brucella and Vibrio cholerae.
    Feeley JC
    J Bacteriol; 1969 Sep; 99(3):645-9. PubMed ID: 5370272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental cholera produced by Vibrio cholerae and choleragenic filtrates: light and electron microscopic findings in the small intestine.
    Chen HC; Schaeffer BT; Walker RI
    Southeast Asian J Trop Med Public Health; 1971 Sep; 2(3):322-36. PubMed ID: 5157926
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.
    Spira WM; Fedorka-Cray PJ
    Infect Immun; 1983 Nov; 42(2):501-9. PubMed ID: 6642640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of experimental cholera. Effect of choleragen on vascular permeability.
    Finkelstein RA; Nye SW; Atthasampunna P; Charunmethee P
    Lab Invest; 1966 Oct; 15(10):1601-9. PubMed ID: 5957286
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular permeability factor of Pseudomonas aeruginosa.
    Kusama H; Suss RH
    Infect Immun; 1972 Mar; 5(3):363-9. PubMed ID: 4629079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry of vibrio cholerae virulence. II. Skin permeability factor-cholera enterotoxin production in a chemically defined medium.
    Callahan LT; Ryder RC; Richardson SH
    Infect Immun; 1971 Nov; 4(5):611-8. PubMed ID: 5170548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.
    Craig JP
    Nature; 1965 Aug; 207(997):614-6. PubMed ID: 5883637
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of an enterotoxin produced by Vibrio cholerae O139.
    Nakashima K; Eguchi Y; Nakasone N
    Microbiol Immunol; 1995; 39(2):87-94. PubMed ID: 7783690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of gamma radiation on the immunobiological and immunochemical properties of cholera exotoxin. IV. The biological and immunochemical properties of purified irradiated choleragen].
    Nedugova GI; Rubtsov IV; Samoĭlenko II
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Sep; (9):90-3. PubMed ID: 6438968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.